<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10320068</article-id>
    <article-id pub-id-type="pmid">37166966</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkad399</article-id>
    <article-id pub-id-type="publisher-id">gkad399</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>GeneRanger and TargetRanger: processed gene and protein expression levels across cells and tissues for target discovery</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0005-9727-559X</contrib-id>
        <name>
          <surname>Marino</surname>
          <given-names>Giacomo B</given-names>
        </name>
        <aff><institution>Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY 10029</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ngai</surname>
          <given-names>Michael</given-names>
        </name>
        <aff><institution>Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY 10029</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Clarke</surname>
          <given-names>Daniel J B</given-names>
        </name>
        <aff><institution>Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY 10029</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Fleishman</surname>
          <given-names>Reid H</given-names>
        </name>
        <aff><institution>Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY 10029</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Deng</surname>
          <given-names>Eden Z</given-names>
        </name>
        <aff><institution>Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY 10029</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xie</surname>
          <given-names>Zhuorui</given-names>
        </name>
        <aff><institution>Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY 10029</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ahmed</surname>
          <given-names>Nasheath</given-names>
        </name>
        <aff><institution>Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY 10029</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6904-1017</contrib-id>
        <name>
          <surname>Ma’ayan</surname>
          <given-names>Avi</given-names>
        </name>
        <!--avi.maayan@mssm.edu-->
        <xref rid="COR1" ref-type="corresp"/>
        <aff><institution>Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY 10029</addr-line>, <country country="US">USA</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 212 281 1153; Fax: +1 212 849 2456; Email: <email>avi.maayan@mssm.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>05</day>
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-05-11">
      <day>11</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>11</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <volume>51</volume>
    <issue>W1</issue>
    <fpage>W213</fpage>
    <lpage>W224</lpage>
    <history>
      <date date-type="accepted">
        <day>02</day>
        <month>5</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>23</day>
        <month>4</month>
        <year>2023</year>
      </date>
      <date date-type="received">
        <day>26</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkad399.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Several atlasing efforts aim to profile human gene and protein expression across tissues, cell types and cell lines in normal physiology, development and disease. One utility of these resources is to examine the expression of a single gene across all cell types, tissues and cell lines in each atlas. However, there is currently no centralized place that integrates data from several atlases to provide this type of data in a uniform format for visualization, analysis and download, and via an application programming interface. To address this need, GeneRanger is a web server that provides access to processed data about gene and protein expression across normal human cell types, tissues and cell lines from several atlases. At the same time, TargetRanger is a related web server that takes as input RNA-seq data from profiled human cells and tissues, and then compares the uploaded input data to expression levels across the atlases to identify genes that are highly expressed in the input and lowly expressed across normal human cell types and tissues. Identified targets can be filtered by transmembrane or secreted proteins. The results from GeneRanger and TargetRanger are visualized as box and scatter plots, and as interactive tables. GeneRanger and TargetRanger are available from <ext-link xlink:href="https://generanger.maayanlab.cloud" ext-link-type="uri">https://generanger.maayanlab.cloud</ext-link> and <ext-link xlink:href="https://targetranger.maayanlab.cloud" ext-link-type="uri">https://targetranger.maayanlab.cloud</ext-link>, respectively.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <graphic xlink:href="gkad399figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>U24CA264250</award-id>
        <award-id>U24CA224260</award-id>
        <award-id>R01DK131525</award-id>
        <award-id>OT2OD030160</award-id>
        <award-id>RC2DK131995</award-id>
        <award-id>U24CA271114</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="12"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Examining the expression level of a single gene/protein across tissues, cell types and cell lines is a practical and useful step for experimental biologists to form novel hypotheses. At the same time, studying abnormal gene and protein expression data in disease can be used to identify genes that can explain disease mechanisms, and such genes may serve as drug targets for therapeutic intervention. There have been several large-scale projects aimed at characterizing baseline normal gene and protein expression across human cell lines, cell types and tissues (Table <xref rid="tbl1" ref-type="table">1</xref>). Such atlasing efforts include the Genotype-Tissue Expression (GTEx) transcriptomics (<xref rid="B1" ref-type="bibr">1</xref>) and proteomics (<xref rid="B2" ref-type="bibr">2</xref>), Tabula Sapiens (<xref rid="B3" ref-type="bibr">3</xref>), BioGPS (<xref rid="B4" ref-type="bibr">4</xref>), HuBMAP (<xref rid="B5" ref-type="bibr">5</xref>), the Human Cell Atlas (HCA) (<xref rid="B6" ref-type="bibr">6</xref>), FANTOM (<xref rid="B7" ref-type="bibr">7</xref>), Illumina Body Map (<xref rid="B8" ref-type="bibr">8</xref>), the Human Protein Atlas (HPA) (<xref rid="B9" ref-type="bibr">9</xref>), Human Cell Landscape (<xref rid="B10" ref-type="bibr">10</xref>), Allen Brain Atlas (<xref rid="B11" ref-type="bibr">11</xref>), Human Proteome Map (HPM) (<xref rid="B12" ref-type="bibr">12</xref>) and the Cancer Cell Line Encyclopedia (CCLE) (<xref rid="B13" ref-type="bibr">13</xref>). At the same time, thousands of transcriptomics datasets are deposited into repositories such as the Gene Expression Omnibus (GEO) (<xref rid="B14" ref-type="bibr">14</xref>) and ArrayExpress (<xref rid="B15" ref-type="bibr">15</xref>). Data from such repositories can be uniformly aligned by projects such as Recount3 (<xref rid="B16" ref-type="bibr">16</xref>) or ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>). From such uniformly aligned resources, tissue and cell line expression can be estimated for all measured genes by aggregating the samples from across studies by their metadata.</p>
    <table-wrap position="float" id="tbl1">
      <label>Table 1.</label>
      <caption>
        <p>Atlasing efforts that provide normal gene and protein expression across cell types, tissues and cell lines</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Resource</th>
            <th rowspan="1" colspan="1">URL</th>
            <th rowspan="1" colspan="1">PMID</th>
            <th rowspan="1" colspan="1">Data type</th>
            <th rowspan="1" colspan="1">Tissues and cell types</th>
            <th rowspan="1" colspan="1">Cell lines</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">ARCHS4*</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://maayanlab.cloud/archs4/" ext-link-type="uri">https://maayanlab.cloud/archs4/</ext-link>
            </td>
            <td rowspan="1" colspan="1">29636450</td>
            <td rowspan="1" colspan="1">Transcriptomics</td>
            <td rowspan="1" colspan="1">251</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">GTEx transcriptomics*</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://gtexportal.org/" ext-link-type="uri">https://gtexportal.org/</ext-link>
            </td>
            <td rowspan="1" colspan="1">23715323</td>
            <td rowspan="1" colspan="1">Transcriptomics</td>
            <td rowspan="1" colspan="1">54</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Tabula Sapiens*</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://tabula-sapiens-portal.ds.czbiohub.org/" ext-link-type="uri">https://tabula-sapiens-portal.ds.czbiohub.org/</ext-link>
            </td>
            <td rowspan="1" colspan="1">35549404</td>
            <td rowspan="1" colspan="1">Transcriptomics</td>
            <td rowspan="1" colspan="1">469</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CCLE transcriptomics*</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://sites.broadinstitute.org/ccle/" ext-link-type="uri">https://sites.broadinstitute.org/ccle/</ext-link>
            </td>
            <td rowspan="1" colspan="1">31068700</td>
            <td rowspan="1" colspan="1">Transcriptomics</td>
            <td rowspan="1" colspan="1">N/A</td>
            <td rowspan="1" colspan="1">1406</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">HPM*</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="http://www.humanproteomemap.org/" ext-link-type="uri">http://www.humanproteomemap.org/</ext-link>
            </td>
            <td rowspan="1" colspan="1">24870542</td>
            <td rowspan="1" colspan="1">Proteomics</td>
            <td rowspan="1" colspan="1">86</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">HPA*</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://www.proteinatlas.org/" ext-link-type="uri">https://www.proteinatlas.org/</ext-link>
            </td>
            <td rowspan="1" colspan="1">28940711</td>
            <td rowspan="1" colspan="1">Proteomics</td>
            <td rowspan="1" colspan="1">257</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">GTEx proteomics*</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://gtexportal.org/" ext-link-type="uri">https://gtexportal.org/</ext-link>
            </td>
            <td rowspan="1" colspan="1">32916130</td>
            <td rowspan="1" colspan="1">Proteomics</td>
            <td rowspan="1" colspan="1">32</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CCLE proteomics*</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://sites.broadinstitute.org/ccle/" ext-link-type="uri">https://sites.broadinstitute.org/ccle/</ext-link>
            </td>
            <td rowspan="1" colspan="1">31978347</td>
            <td rowspan="1" colspan="1">Proteomics</td>
            <td rowspan="1" colspan="1">N/A</td>
            <td rowspan="1" colspan="1">378</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">BioGPS</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="http://biogps.org/" ext-link-type="uri">http://biogps.org/</ext-link>
            </td>
            <td rowspan="1" colspan="1">19919682, 23175613, 26578587</td>
            <td rowspan="1" colspan="1">Transcriptomics, proteomics</td>
            <td rowspan="1" colspan="1">84</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">HCA</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://www.humancellatlas.org/" ext-link-type="uri">https://www.humancellatlas.org/</ext-link>
            </td>
            <td rowspan="1" colspan="1">34750578</td>
            <td rowspan="1" colspan="1">Transcriptomics</td>
            <td rowspan="1" colspan="1">N/A</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Illumina Body Map</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30611" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30611</ext-link>
            </td>
            <td rowspan="1" colspan="1">33378673</td>
            <td rowspan="1" colspan="1">Transcriptomics</td>
            <td rowspan="1" colspan="1">16</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Human Cell Landscape</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://db.cngb.org/HCL/" ext-link-type="uri">https://db.cngb.org/HCL/</ext-link>
            </td>
            <td rowspan="1" colspan="1">32214235</td>
            <td rowspan="1" colspan="1">Transcriptomics</td>
            <td rowspan="1" colspan="1">60</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Allen Brain Atlas</td>
            <td rowspan="1" colspan="1">
              <ext-link xlink:href="https://portal.brain-map.org/" ext-link-type="uri">https://portal.brain-map.org/</ext-link>
            </td>
            <td rowspan="1" colspan="1">23193282</td>
            <td rowspan="1" colspan="1">Transcriptomics</td>
            <td rowspan="1" colspan="1">414</td>
            <td rowspan="1" colspan="1">N/A</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="T1TFN1">
          <p>*Included in GeneRanger and TargetRanger.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>Most of these resources provide visualization of the expression of a gene or a protein across the profiled cell types, cell lines and tissues. Such functionality is critical for extracting useful knowledge from such data for hypothesis generation. For example, the GTEx portal provides visualization of the expression of each gene as a violin plot with different colors. Tabula Sapiens data from single cells are served as interactive UMAP (<xref rid="B18" ref-type="bibr">18</xref>) plots via an interactive users interface called CELLxGENE. BioGPS, which is one of the oldest resources, displays gene expression across human tissues as colored bar charts. HuBMAP data can be interrogated with several tools, including a dashboard interface called visual integration tool for exploration of spatial single-cell experiments (Vitessce) (<xref rid="B19" ref-type="bibr">19</xref>). Several atlases, for example, HPM, HPA, HCA and HuBMAP, display the expression of genes and proteins on a silhouette of the human body. Each of these resources provides valuable data and visualizations; however, so far, there are no published efforts that attempt to merge and compare expression levels across atlases.</p>
    <p>Furthermore, gene and protein expression across normal cell types, tissues and cell lines can be used as a reference for identifying genes and proteins that are aberrantly and specifically expressed only in the disease. There are indeed genes and proteins that are expressed only at a specific developmental time window, or expressed only under extreme pathophysiological conditions. In disease pathologies, these genes are hijacked to contribute to disease mechanisms, for example in cancer or in aging. Previous studies demonstrated that candidates for immunotherapeutic targeting of disease cells may be identified by comparing disease cells from patients profiled with transcriptomics to normal tissue and cell type expression from existing atlases. For example, Bosse <italic toggle="yes">et al.</italic> (<xref rid="B20" ref-type="bibr">20</xref>) showed the potential of this approach by comparing the expression of a neuroblastoma tumor to the GTEx tissue expression atlas to prioritize potential protein targets that are highly expressed in the tumor and lowly expressed across all GTEx tissues. Identified targets were then filtered to include only those that encode cell surface proteins given their potential to be targeted by immunotherapeutic strategies such as antibody–drug conjugates (<xref rid="B21" ref-type="bibr">21</xref>) and chimeric antigen receptor (CAR) T-cell therapy (<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B23" ref-type="bibr">23</xref>). Similarly, Orentas <italic toggle="yes">et al.</italic> identified cell surface protein targets for 12 pediatric cancers utilizing expression from normal and cancerous tissues. They identified targets that are already tested in clinical trials as well as novel targets using a two-tailed <italic toggle="yes">t</italic>-test (<xref rid="B24" ref-type="bibr">24</xref>). In another study, integrated transcriptomics and proteomics profiling was utilized to discover targets for prostate cancer (<xref rid="B25" ref-type="bibr">25</xref>). The top identified target, CEACAM5, was demonstrated to be an effective target of CAR T-cell immunotherapy, inducing cytotoxicity in prostate cancer cell lines. In a different study, glycoprotein capture proteomics from the myeloma surface proteome was used to identify targets for immunotherapy as well as proteins associated with drug resistance (<xref rid="B26" ref-type="bibr">26</xref>).</p>
    <p>Several web-based resources have recently emerged to provide support for systematically identifying drugs and targets from transcriptomics profiling. For example, the Open Cancer TherApeutic Discovery (OCTAD) (<xref rid="B27" ref-type="bibr">27</xref>) platform integrates gene expression data from cancer patients, normal tissues (<xref rid="B1" ref-type="bibr">1</xref>) and drug perturbation followed by expression (<xref rid="B28" ref-type="bibr">28</xref>), together with drug target knowledge to enable virtual screening of compounds for individual patients. OCTAD also supports the upload of data from differential expression analysis to have it integrated with the OCTAD pipeline. OCTAD is similar to TargetRanger in regard to using normal tissue gene expression from GTEx (<xref rid="B1" ref-type="bibr">1</xref>). However, OCTAD is using the GTEx data for computing differential expression signatures for small molecule query against the L1000 data. Hence, in that sense it is different from TargetRanger and more like other tools that we previously published, namely L1000CDS2 (<xref rid="B29" ref-type="bibr">29</xref>), L1000FWD (<xref rid="B30" ref-type="bibr">30</xref>), SigCom LINCS (<xref rid="B31" ref-type="bibr">31</xref>) and the LINCS Canvas Browser (<xref rid="B32" ref-type="bibr">32</xref>). Since many cancer samples in the public domain do not have normal tissue, OCTAD uses few normal tissue expression samples from the GTEx data to prepare signatures for small molecule search. In contrast, TargetRanger aims to identify single cell surface genes that are highly expressed in the tumor and lowly expressed across all other normal tissues and cell types.</p>
    <p>QSurface (<xref rid="B33" ref-type="bibr">33</xref>) is a desktop application that enables users to query for target antigens, cell surface proteins, and mutations across 15 cancers using transcriptomics datasets from these cancers. QSurface is more like TargetRanger but is different in many aspects. QSurface does not compare the expression in the tumor to normal tissue atlases, it considers only 519 membrane targets and it is applied to only 14 cancer subtypes. QSurface carefully considers mutations, and the software is a desktop application, not a web server. One of the limitations of most related applications is that they do not consider proteomics data, which have recently become more available for normal tissue and disease. Since the transcriptome does not always correlate with the proteome, considering proteomics data can be used as an additional filter to increase the likelihood that the computationally identified potential target is effective and selective.</p>
    <p>Here, we introduce GeneRanger and TargetRanger, two related web server applications that can be used to explore the expression of human genes across human transcriptomics and proteomics atlases, as well as to identify targets for cell removal. By comparing uploaded RNA-seq samples with processed transcriptomics and proteomics data from several atlases, TargetRanger identifies genes that are highly expressed in the target cells while lowly expressed across normal human cell types and tissues. Additionally, genes that encode for cell surface proteins or secreted proteins can be prioritized. At the same time, GeneRanger provides the expression of a single gene or a protein across many human cell types, tissues and cell lines based on the same processed data from several transcriptomics and proteomics atlasing resources.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>Processing the data from the atlases</title>
      <sec id="SEC2-1-1">
        <title>Gene ID mapping</title>
        <p>Descriptions for each gene are sourced from NCBI (<xref rid="B34" ref-type="bibr">34</xref>) and stored in the GeneRanger/TargetRanger PostgreSQL database. A Python script is used to query the NCBI E-utilities application programming interface (API) and store information for each of the genes contained in the PostgreSQL database. These gene descriptions are then stored in the database to improve efficiency, not requiring the use of the NCBI API.</p>
      </sec>
      <sec id="SEC2-1-2">
        <title>The ARCHS4 normal tissues and cell type background</title>
        <p>The sample descriptions from the ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>) metadata were automatically searched for tissue and cell type terms. To create files with tissue and cell type terms, metadata files were first downloaded from CellMarker (<xref rid="B35" ref-type="bibr">35</xref>). To generate a cell type to tissue mapping file, the ‘Human_Cell_Markers.txt’ file was downloaded from CellMarker. The ‘tissueType’ and ‘cellName’ columns were used. This file was manually cleaned to remove duplicate cell types to tissue mappings and rare cell types. Some tissues were renamed to broader tissue types for simplification, for example endometrium to uterus. This mapping file was further reduced by keeping only cell types that were present in the ARCHS4 sample descriptions. Finally, a few tissue types without cell type mappings were manually added, for example stomach, adrenal cortex, intestine, oral cavity, colorectal and gallbladder. All terms were standardized by removing symbols and converting them to lowercase. ARCHS4 samples were then labeled by tissue type using a basic text search. First, sample descriptions were searched for cell types and then labeled with the corresponding tissue. If no cell type was detected, a basic text search was performed with tissue names. Samples that had multiple labels were manually labeled by reading the sample description. Expression statistics were then computed per labeled tissue and cell type across the applicable samples.</p>
      </sec>
      <sec id="SEC2-1-3">
        <title>The GTEx background</title>
        <p>From GTEx version 8 (<xref rid="B1" ref-type="bibr">1</xref>), gene and transcript counts were processed from ∼800 donors across 47 tissues. We produced summary statistics across all donors and replicates for each tissue type.</p>
      </sec>
      <sec id="SEC2-1-4">
        <title>The Tabula Sapiens background</title>
        <p>The processed data from Tabula Sapiens (<xref rid="B3" ref-type="bibr">3</xref>) were downloaded and filtered to include only cells profiled with 10x Genomics. Tissue and cell type labels were aggregated, and counts were then grouped per donor, summed and expression statistics were computed across donors.</p>
      </sec>
      <sec id="SEC2-1-5">
        <title>The CCLE background</title>
        <p>CCLE transcriptomics data were obtained from the DepMap portal (<xref rid="B36" ref-type="bibr">36</xref>) (CCLE_RNAseq_reads.csv) and the ‘DepMap_ID’ was aligned with the ‘stripped_cell_line_name’ column from the CCLE sample info file (CCLE_sample_info.csv). For cell lines with multiple expression values for a single gene, the mean value was taken. CCLE proteomics data were also obtained from the DepMap portal (protein_quant_current_normalized.csv.gz) and cell line names were parsed and retained.</p>
      </sec>
      <sec id="SEC2-1-6">
        <title>The HPA background</title>
        <p>Protein expression from HPA (<xref rid="B37" ref-type="bibr">37</xref>) version 21.1 was retrieved from the HPA portal. Protein expression levels and reliability scores are saved in the GeneRanger database by gene name. Expression levels are four discrete levels: not detected, low, medium, and high.</p>
      </sec>
      <sec id="SEC2-1-7">
        <title>The HPM background</title>
        <p>HPM (<xref rid="B12" ref-type="bibr">12</xref>) data were retrieved from the HPM portal. Protein expression levels are based on average spectral counts for each protein in normal tissues and cell types. Expression statistics were computed across donors.</p>
      </sec>
      <sec id="SEC2-1-8">
        <title>The GTEx proteomics project background</title>
        <p>GTEx protein expression data (<xref rid="B38" ref-type="bibr">38</xref>) were collected with tandem mass tag mass spectrometry to quantify protein expression across tissues. The log relative abundance of proteins and tissue specificity scores were retrieved for each protein and mapped to the corresponding gene Ensembl ID. Expression statistics were computed across donors.</p>
      </sec>
    </sec>
    <sec id="SEC2-2">
      <title>Membrane and secreted protein filters</title>
      <p>Genes encoding transmembrane proteins are compiled from the intersection between COMPARTMENTS (<xref rid="B39" ref-type="bibr">39</xref>), where a filter was applied for ‘Plasma membrane’ and ‘Cell surface’ subcellular localization with a confidence score ≥3, and HPA (<xref rid="B9" ref-type="bibr">9</xref>) membrane proteins, where a filter was applied for ‘Evidence at protein level’ and removal of genes with ‘Low tissue specificity’. The secreted protein list is also sourced from HPA, where a filter was applied for ‘Evidence at protein level’ and removal of genes with ‘Low tissue specificity’.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Web server development</title>
      <p>GeneRanger and TargetRanger are web servers created using React inside the Next.js framework. Many of the icons and components are sourced from the Material-UI library. The processed data from each resource are stored in a PostgreSQL v14 database that is shared by both websites and accessed from the web apps using Prisma. Expression data across resources are stored as normalized tables and accessed from the GeneRanger site as a PostgreSQL view. TargetRanger queries the PostgreSQL database, which utilizes the SciPy (<xref rid="B40" ref-type="bibr">40</xref>) Python library to identify targets with a two-tailed Welch’s <italic toggle="yes">t</italic>-test. Average expressions, standard deviations and counts across each of the background transcriptomics datasets are computed and stored as a materialized view for efficient access. Then, the Plotly.js library is used for rendering the plots. GeneRanger and TargetRanger are containerized using Docker and deployed on a cluster managed by Kubernetes on AWS.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Systematic application of TargetRanger to TCGA</title>
      <p>The Cancer Genome Atlas (TCGA) (<xref rid="B41" ref-type="bibr">41</xref>) cancer type gene counts were obtained from the Firehose Broad GDAC website. For each tumor type, the Leiden community detection algorithm (<xref rid="B42" ref-type="bibr">42</xref>) was applied with the scanpy Python package (<xref rid="B43" ref-type="bibr">43</xref>) using the 1000 most variable log-transformed genes. To visualize the identified clusters, dimensionality reduction was applied with UMAP (<xref rid="B18" ref-type="bibr">18</xref>). Mutation data for each sample were sourced from Genomic Data Commons (<xref rid="B44" ref-type="bibr">44</xref>) and the top 10 most common gene-associated mutations for each cluster were retained. Gene counts for each tumor subtype were submitted to the TargetRanger API to identify subtype-specific targets. For each cluster of patients, targets were prioritized using the ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>), GTEx (<xref rid="B1" ref-type="bibr">1</xref>) and Tabula Sapiens (<xref rid="B3" ref-type="bibr">3</xref>) normal tissue backgrounds. Targets were filtered for membrane proteins using the COMPARTMENTS database (<xref rid="B39" ref-type="bibr">39</xref>) in conjunction with HPA (<xref rid="B12" ref-type="bibr">12</xref>) utilizing the membrane filtering feature included in TargetRanger. The top identified candidates for each cluster are reported in heatmaps. We identified significantly differentially expressed candidates as those with an adjusted <italic toggle="yes">P</italic>-value of &lt;0.01. In the heatmaps, the top 30 targets for each cluster were retained and visualized by frequency across subtypes.</p>
    </sec>
    <sec id="SEC2-5">
      <title>Manual curation of identifiers across atlases</title>
      <p>Cell and tissue types across atlases in GeneRanger and TargetRanger were manually mapped to Cell Ontology (CL) (<xref rid="B45" ref-type="bibr">45</xref>) and BRENDA Tissue Ontology (BTO) (<xref rid="B46" ref-type="bibr">46</xref>) identifiers, respectively. For the GTEx (<xref rid="B1" ref-type="bibr">1</xref>), ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>) and HPM (<xref rid="B12" ref-type="bibr">12</xref>) tissues and cell types, all terms were mapped to the single most specific identifier possible. For instance, tissues labeled ‘Brain – Cerebellum’ were mapped to the BTO identifier for ‘cerebellum’, or BTO:0000232; meanwhile, ‘Cells – Cultured fibroblasts’ were mapped to the identifier for ‘fibroblasts’, or CL:0000057. Fetal tissues from HPM were mapped to their corresponding adult tissue type. Cells from Tabula Sapiens and HPA were each mapped to both a BTO identifier and a CL identifier, representing the tissue of origin and the specific cell type. As an example, the term ‘Skin – T cell’ is mapped to both BTO:0001253 for ‘skin’ and CL:0000084 for ‘T cell’. In cases where the specific tissue or cell subtype did not match an existing identifier, the closest parent tissue or organ term was used.</p>
    </sec>
    <sec id="SEC2-6">
      <title>Comparing GTEx proteomics and transcriptomics</title>
      <p>To compare the GTEx proteomics and transcriptomics expression profiles across tissues, we first manually mapped tissue terms to BTO identifiers (<xref rid="B47" ref-type="bibr">47</xref>). Then, we computed global mean and standard deviations across all tissues and genes for each data set. Joint plots are constructed by aligning the original statistics via the mapped BTO identifiers and adjusting the statistics by the computed global mean and standard deviation resulting in a <italic toggle="yes">z</italic>-score. Such normalization maintains the relative differences between each tissue for a given gene and its corresponding protein while making the overall distributions more comparable. For any given gene and its matching protein product, two box plots are produced illustrating the expression relative to the global mean. Additionally, a scatter plot is produced with the normalized scores as the coordinates for each tissue term.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS</title>
    <p>GeneRanger and TargetRanger are web server applications that utilize a database containing transcriptomics and proteomics data sourced from ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>), GTEx (<xref rid="B1" ref-type="bibr">1</xref>), Tabula Sapiens (<xref rid="B3" ref-type="bibr">3</xref>), CCLE (<xref rid="B13" ref-type="bibr">13</xref>), HPA (<xref rid="B37" ref-type="bibr">37</xref>) and HPM (<xref rid="B12" ref-type="bibr">12</xref>) for visualization, comparison, programmatic access, download and target identification. Upon entering the GeneRanger site, expression data are displayed for the gene A2M because it is the first gene sorted alphabetically. At the top of the page, a tab is provided for each resource, facilitating toggling between the available box plots. The footer contains links to access the GeneRanger video tutorial, the GitHub repository, the API documentation and the download page. TargetRanger offers the ability to upload RNA-seq data collected from a specific cell type or a tissue. It then computes significantly upregulated genes identified in the input samples compared to normal cell type and tissue expression from ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>), GTEx (<xref rid="B1" ref-type="bibr">1</xref>) or Tabula Sapiens (<xref rid="B3" ref-type="bibr">3</xref>) utilizing the two-tailed Welch’s <italic toggle="yes">t</italic>-test. Targets may be additionally filtered to include only those genes that encode for membrane proteins or secreted proteins. Results are available for every target where the expression of the gene from the input is compared directly to the expression of the gene in the ARCHS4, GTEx and Tabula Sapiens background. The normal expression of the gene can be further examined by viewing it in the remaining atlases. Additionally, TargetRanger offers export, descriptions, external links and visualizations for each identified potential target.</p>
    <sec id="SEC3-1">
      <title>Visualizing the expression of single human genes across tissues, cell types and cell lines</title>
      <p>GeneRanger has a user-friendly interface for investigating the expression of human gene symbols across the available proteomics and transcriptomics atlases. Users enter a gene symbol in the input form on the top left of the page to instantly receive results (Figure <xref rid="F1" ref-type="fig">1</xref>). Autocomplete is implemented to assist users with selecting the desired gene from a list of options. Expression for the queried gene is displayed for one resource at a time as box or dot plots. GeneRanger displays the NCBI Gene database description of the chosen gene (<xref rid="B34" ref-type="bibr">34</xref>), links to other gene pages for additional information and a description of the currently selected resource. Users can switch between resources by selecting a resource from the tabs located above the plots, or via switches that are available at the left side of the page. This functionality provides a quick way to compare the expression of a gene across transcriptomics and proteomics resources. For example, tumor necrosis factor (TNF) is highly expressed in T memory cells based on processed data from ARCHS4 (Figure <xref rid="F1" ref-type="fig">1</xref>), while HPA shows high expression of TNF in adult liver and CD8<sup>+</sup> T cells. Additionally, users may download the data contained within each plot as either a CSV or a JSON file with the ‘download plot data’ button provided at the top right corner of each plot.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>The GeneRanger interface with TNF transcriptomics expression selected. The interface of GeneRanger includes an autocomplete input box at the top left of the page. Users can toggle between resources using either the switches on the left side of the page, or the tabs at the top of the page. TNF expression in ARCHS4 is displayed as an example.</p>
        </caption>
        <graphic xlink:href="gkad399fig1" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-2">
      <title>Use case 1: target identification for lung squamous cell carcinoma</title>
      <p>TargetRanger can utilize these data to identify cancer subtype-specific targets for single patients or clusters of patients who share similar expression vectors. Files containing gene expression from a patient, or a cluster of patients, can be directly uploaded to TargetRanger, and a background with which to compare the uploaded data can be chosen from the switches to the left of the upload box or the dropdown selector inside the upload box (Figure <xref rid="F2" ref-type="fig">2</xref>). To demonstrate how TargetRanger can be used to prioritize targets for cell removal, we reanalyzed data from a published study that collected tumor cells from patients with lung squamous cell carcinoma (GSE49155) (<xref rid="B48" ref-type="bibr">48</xref>). The study compared the transcriptome from lung tissue isolated with laser dissection from normal tissue, premalignant lesions and tumors. From this study, we selected three RNA-seq samples of isolated tumor cells from patient 4.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>TargetRanger upload interface. TargetRanger provides users with a data upload form where users can upload and submit a file that contains RNA-seq samples for target identification. The user needs to select the background and choose whether to prioritize genes that encode for membrane or secreted proteins. An example file is available for submission and download.</p>
        </caption>
        <graphic xlink:href="gkad399fig2" position="float"/>
      </fig>
      <p>After uploading this dataset to TargetRanger, the results from a two-tailed Welch's <italic toggle="yes">t</italic>-test comparing the gene expression data from the uploaded file to the chosen background are displayed in a table that contains the target name, <italic toggle="yes">t</italic>-statistic, <italic toggle="yes">P</italic>-value, log fold change and the ability to filter for targets that encode cell surface or secreted proteins (Figure <xref rid="F3" ref-type="fig">3A</xref>). Additional information about each target is provided with links to gene pages available from ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>), Harmonizome (<xref rid="B49" ref-type="bibr">49</xref>), PrismEXP (<xref rid="B50" ref-type="bibr">50</xref>) and GDLPA (<xref rid="B51" ref-type="bibr">51</xref>). Identified targets are also visualized as box plots across the existing resources either by selecting the row in the table or by searching for the target in a search box below the table (Figure <xref rid="F3" ref-type="fig">3A</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>TargetRanger results page. (<bold>A</bold>) The results table produced upon submission of a valid file to TargetRanger. The table contains targets that are highly expressed in the input dataset compared to all tissues and cell types from the selected background with a <italic toggle="yes">P</italic>-value &lt;0.05. Filters for transmembrane and secreted proteins can be turned on and off with switches above the table. Individual targets can be selected for visualization as box plots by clicking the respective row in the table or by searching for the target in the search bar below the table. (<bold>B</bold>) Targets are visualized in box plots alongside the expression of the gene in the selected background. Here, Tabula Sapiens is selected as an example. The box plot contains over 400 boxes, and thus, the plot is cut off to show only the top cell types where the target gene is most highly expressed.</p>
        </caption>
        <graphic xlink:href="gkad399fig3" position="float"/>
      </fig>
      <p>For the ARCHS4, GTEx transcriptomics and Tabula Sapiens backgrounds, the uploaded dataset statistics are shown above the expression levels for the target in the selected resource. In the produced table, the identified target PTPRZ1 is one of the most significantly upregulated targets (<italic toggle="yes">P</italic>-value = 4.4e−12) (Figure <xref rid="F3" ref-type="fig">3A</xref>). PTPRZ1 is a receptor tyrosine-protein phosphatase. It is localized to the cell membrane, but it is also found in the cytoplasm (<xref rid="B52" ref-type="bibr">52</xref>). PTPRZ1 has been observed to be highly expressed in small-cell lung carcinoma before, supporting tumor progression, and was proposed as a potential therapeutic target (<xref rid="B53" ref-type="bibr">53</xref>). Additionally, PTPRZ1 expression was shown to be integrally involved in the development and metastasis of oral squamous cell carcinoma, and was suggested as a marker and as a potential target (<xref rid="B54" ref-type="bibr">54</xref>). In Tabula Sapiens, PTPRZ1 was expressed relatively highly in basal cells of the trachea, tongue and lung, but lowly or not expressed in other tissues and cell types (Figure <xref rid="F3" ref-type="fig">3B</xref>). GTEx transcriptomics and protein expression of PTPRZ1 in HPA and HPM suggest high expression in various brain regions, including the cerebellum, amygdala and the frontal cortex. PTPRZ1 was identified as a significant target in the ARCHS4 and Tabula Sapiens backgrounds for patient 4 of GSE49155, as well as for patient 3 in all backgrounds, and for patient 1 in Tabula Sapiens (Figure <xref rid="F4" ref-type="fig">4</xref>). Utilizing the multiple backgrounds provides the ability to find consensus targets across databases. Additionally, when comparing identified targets across individual patients, or clusters of patients, some targets are specific, underscoring the importance and potential of personalized target identification with TargetRanger. For example, patient 2 does share targets with the other patients, suggesting that this patient may respond differently to targeted immunotherapies compared with patients 3 and 4, who share many targets (Figure <xref rid="F4" ref-type="fig">4</xref>). It is important to note that TargetRanger analysis can identify highly significant targets that may be expressed at the same level or even lower than its expression in some normal tissues and cell types. Hence, it is possible to still obtain a small <italic toggle="yes">P</italic>-value for a potential target if the identified target is highly expressed in the tumor and lowly expressed in most tissues and cell types, but not all tissues and cell types.</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>TargetRanger results from lung squamous cell carcinoma tumors from four patients (GSE49155). Top ranked targets across four tumors from four patients profiled with RNA-seq. Targets are sorted by most overlap across backgrounds and patients. Patients are clustered by their target profile similarity.</p>
        </caption>
        <graphic xlink:href="gkad399fig4" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-3">
      <title>Comparing the background datasets</title>
      <p>Currently, the GeneRanger and TargetRanger database has eight different datasets: GTEx transcriptomics (<xref rid="B1" ref-type="bibr">1</xref>), ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>), Tabula Sapiens (<xref rid="B3" ref-type="bibr">3</xref>), CCLE transcriptomics (<xref rid="B13" ref-type="bibr">13</xref>), HPM (<xref rid="B38" ref-type="bibr">38</xref>), HPA (<xref rid="B12" ref-type="bibr">12</xref>), GTEx proteomics (<xref rid="B38" ref-type="bibr">38</xref>) and CCLE proteomics (<xref rid="B13" ref-type="bibr">13</xref>) (Table <xref rid="tbl1" ref-type="table">1</xref>). ARCHS4, GTEx, Tabula Sapiens and CCLE transcriptomics all provide transcriptomics data collected in different settings with different assays. ARCHS4 contains a wide range of platforms and studies. By combining the samples of thousands of experiments from GEO, covering a wide variety of tissues, cell types and cell lines, it is expected that outliers will be automatically filtered out. GTEx transcriptomics provides bulk RNA-seq data for many human tissues, while Tabula Sapiens single-cell RNA-seq data provide expression levels for hundreds of cell types and were collected by a different and unique assay. While collectively these resources cover a robust collection of tissues, cell types and cell lines from both bulk and single-cell RNA-seq, it is unclear how much concordance is observed across resources. At the same time, HPM, HPA, GTEx proteomics and CCLE proteomics provide protein expression information that was collected and reported in even more unique methods. HPM contains information from both adult and fetal tissues. HPA reports protein expression levels as discrete levels such as ‘low’, ‘medium’ and ‘high’, while the human cell types and tissues only partial overlap across resources.</p>
      <p>Aligning the labels across pairs of resources can be used for direct comparisons between resources to examine concordance across tissues, cell types and cell lines. However, such alignment is not trivial. The challenge is that terms are often ambiguous and organized in hierarchies. Using the CL (<xref rid="B45" ref-type="bibr">45</xref>) and BTO (<xref rid="B46" ref-type="bibr">46</xref>) identifiers, we manually mapped all the terms across the atlases and obtained partial overlap (Figure <xref rid="F5" ref-type="fig">5</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). The most consistent overlap was achieved for GTEx proteomics and transcriptomics, and this enables the interactive visualization of the same gene and its protein product in the same interactive plots on GeneRanger. In addition, for mapped tissues across the ARCHS4 and GTEx transcriptomics atlases, expression correlations across nine overlapping tissues suggest good agreement between these two transcriptomics resources, where the lowest Pearson correlation coefficient (PCC) was 0.87 in the testis (Figure <xref rid="F6" ref-type="fig">6A</xref>). Slightly lower concordance was observed between GTEx and Tabula Sapiens where expression from similar tissues has PCCs ranging from 0.74 to 0.91, although the majority are above 0.85 (Figure <xref rid="F6" ref-type="fig">6B</xref>). When comparing ARCHS4 and Tabula Sapiens, the correlations are generally less consistent and lower (Figure <xref rid="F6" ref-type="fig">6C</xref>). A few of the cell types showed relatively high correlations, for example basophil (PCC: 0.87) and the B cell (PCC: 0.81), while for sperm the correlation was lower but still significant (PCC: 0.32). When comparing CCLE transcriptomics and proteomics, lower correlations are observed. In the nine cell lines plotted, the highest PCC was 0.41 (Figure <xref rid="F6" ref-type="fig">6D</xref>), highlighting the greater differences that exist between transcriptomics and proteomics expression datasets.</p>
      <fig position="float" id="F5">
        <label>Figure 5.</label>
        <caption>
          <p>SuperVenn diagrams of overlapping terms across atlases. (<bold>A</bold>) Overlap between BTO and (<bold>B</bold>) CL terms across the different atlases in GeneRanger and TargetRanger. Each row represents a set of identifiers from the labeled atlas, and vertically overlapping sections indicate intersections between sets of identifiers from each atlas. The number of terms in each intersection is shown across the bottom, while the number of atlases to which those terms belong is shown across the top.</p>
        </caption>
        <graphic xlink:href="gkad399fig5" position="float"/>
      </fig>
      <fig position="float" id="F6">
        <label>Figure 6.</label>
        <caption>
          <p>Comparison of resources across similar tissues, cell types and cell lines with PCCs. (<bold>A</bold>) Log-transformed ARCHS4 and GTEx expression correlation in nine tissues, where each point represents a measured gene. (<bold>B</bold>) Log-transformed GTEx transcriptomics and Tabula Sapiens expression correlation across nine cell lines. (<bold>C</bold>) Log-transformed ARCHS4 and Tabula Sapiens expression correlations across nine cell types and tissues. (<bold>D</bold>) Log-transformed CCLE transcriptomics and proteomics expression correlations across nine cell lines.</p>
        </caption>
        <graphic xlink:href="gkad399fig6" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-4">
      <title>Systematic application of TargetRanger to TCGA</title>
      <p>TCGA has collected data from thousands of pan-cancer patients (<xref rid="B41" ref-type="bibr">41</xref>). TargetRanger can be utilized to analyze these data to identify cancer subtype-specific targets for single patients or clusters of patients who share similar expression vectors. Thus, we sought to systematically identify membrane targets across the TCGA cancer types. Each cancer type from TCGA was first analyzed to identify subtypes from the RNA-seq samples with unsupervised clustering. Each cancer type formed 2–15 clusters with between 4 and 390 samples each as determined by the Leiden algorithm (<xref rid="B42" ref-type="bibr">42</xref>). Interactive UMAP plots (<xref rid="B18" ref-type="bibr">18</xref>), as well as common mutations for each cluster, are provided as a dedicated page that is linked to the TargetRanger landing page. Any cluster of samples from a particular cancer type can be submitted to TargetRanger to investigate the prioritized target genes and their expression across the TCGA samples compared to normal cell and tissue types from transcriptomics and proteomics atlases. We systemically submitted each of the cluster subtypes across all cancer types to TargetRanger using the TargetRanger API to produce heatmaps where the rows are tumor subtypes and columns are the top significant (adjusted <italic toggle="yes">P</italic>-value &lt;0.01) targets identified by TargetRanger, sorted by frequency across subtypes and filtered for targets identified using the ARCHS4 (<xref rid="B17" ref-type="bibr">17</xref>), GTEx (<xref rid="B1" ref-type="bibr">1</xref>) and Tabula Sapiens (<xref rid="B3" ref-type="bibr">3</xref>) atlases as backgrounds.</p>
      <p>This pipeline identifies targets that appear broadly across the cancer types and subtypes as well as unique targets appearing only once for one subtype in one cancer type. Importantly, through this analysis, we identify multiple targets that have been previously implicated in cancer progression. One such target, highly ranked for multiple cancer types, is the lipolysis-stimulated lipoprotein receptor (LSR). LSR has an important role in breast cancer tumorigenesis (<xref rid="B55" ref-type="bibr">55</xref>). LSR is also known to promote cancer cell growth and migration in lung cancer (<xref rid="B56" ref-type="bibr">56</xref>). TargetRanger identified LSR as a target for several clusters in lung and breast cancers from TCGA. Similarly, TargetRanger identified PGRMC1 as a target for three of the four clusters of uterine carcinosarcoma. PGRMC1 is known to be involved in cancer growth and chemoresistance in endometrial cancers (<xref rid="B57" ref-type="bibr">57</xref>,<xref rid="B58" ref-type="bibr">58</xref>).</p>
    </sec>
    <sec id="SEC3-5">
      <title>Accessing the GeneRanger and TargetRanger database via API and direct download</title>
      <p>The GeneRanger database and functionality can be accessed through an API. The API enables programmatic use in workflows and integration with external resources. Currently, the API supports POST requests that specify the gene and resources. The request returns all the information relating to the chosen gene and specified resources. Documentation for the API is linked at the footer of the landing page. The GeneRanger database can be downloaded via the ‘Download’ page. This page provides .tsv files for each of the resources implemented by GeneRanger in a ‘standard’ format. The download access provides a non-programmatic approach for users to access and utilize the processed data available for GeneRanger and TargetRanger.</p>
    </sec>
  </sec>
  <sec sec-type="discussion" id="SEC4">
    <title>DISCUSSION</title>
    <p>The GeneRanger and TargetRanger web server applications serve a collection of processed transcriptomics and proteomics data from normal tissues and cells for the purpose of exploring the basal expression of a gene or a protein in normal physiology. These assembled resources contain transcriptomics and proteomics data for human coding genes and proteins across many human tissues, cell types and cell lines. However, much effort can be made to improve the resource by better aligning terms across resources, providing the expression of noncoding genes, supporting other organisms besides human, providing further support for isoforms and slice variants, and improving the algorithm that is used to identify differentially expressed targets. Additionally, GeneRanger currently only supports querying by gene or protein name, but not by cell, tissue or cell line. Also, while it is possible to compare expression data across atlases, the user must switch between pages to do so. In the future, we plan to add support for mouse genes, noncoding genes, and customized analysis and visualization of more readily available processed datasets. Furthermore, we plan to add features that will enable querying by tissue, cell type or cell line for GeneRanger, as well as provide more canned disease samples ready to be uploaded to TargetRanger. Regardless of these limitations, the GeneRanger and TargetRanger web server applications can facilitate data exploration that may lead to hypothesis generation for many applications in molecular and cell biology, genetics, genomics and pharmacology.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>The GeneRanger web server application is available at <ext-link xlink:href="https://generanger.maayanlab.cloud" ext-link-type="uri">https://generanger.maayanlab.cloud</ext-link>.</p>
    <p>The TargetRanger web server application is available at <ext-link xlink:href="https://targetranger.maayanlab.cloud" ext-link-type="uri">https://targetranger.maayanlab.cloud</ext-link>.</p>
    <p>The GeneRanger source code is available at <ext-link xlink:href="https://github.com/MaayanLab/GeneRanger" ext-link-type="uri">https://github.com/MaayanLab/GeneRanger</ext-link>.</p>
    <p>The TargetRanger source code is available at <ext-link xlink:href="https://github.com/MaayanLab/TargetRanger" ext-link-type="uri">https://github.com/MaayanLab/TargetRanger</ext-link>.</p>
    <p>Permanent DOI for datasets is <ext-link xlink:href="https://doi.org/10.5281/zenodo.7883678" ext-link-type="uri">https://doi.org/10.5281/zenodo.7883678</ext-link>.</p>
    <p>The processed datasets served on GeneRanger and TargetRanger are available at <ext-link xlink:href="https://generanger.maayanlab.cloud/download" ext-link-type="uri">https://generanger.maayanlab.cloud/download</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkad399_Supplemental_File</label>
      <media xlink:href="gkad399_supplemental_file.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad399#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>National Institutes of Health [U24CA264250, U24CA224260, R01DK131525, OT2OD030160, RC2DK131995 and U24CA271114]. Funding for open access charge: National Institutes of Health [U24CA224260].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><collab>GTEx Consortium</collab><article-title>The Genotype-Tissue Expression (GTEx) project</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>580</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">23715323</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>S.</given-names></string-name>, <string-name><surname>Jian</surname><given-names>R.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Chan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>G.</given-names></string-name>, <string-name><surname>Fang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>GTEx</surname><given-names>Consortium</given-names></string-name><etal>et al</etal>.</person-group><article-title>A quantitative proteome map of the human body</article-title>. <source>Cell</source>. <year>2020</year>; <volume>183</volume>:<fpage>269</fpage>–<lpage>283</lpage>.<pub-id pub-id-type="pmid">32916130</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>The</surname><given-names>Tabula Sapiens Consortium</given-names></string-name>, <string-name><surname>Jones</surname><given-names>R.C.</given-names></string-name>, <string-name><surname>Karkanias</surname><given-names>J.</given-names></string-name>, <string-name><surname>Krasnow</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Pisco</surname><given-names>A.O.</given-names></string-name>, <string-name><surname>Quake</surname><given-names>S.R.</given-names></string-name>, <string-name><surname>Salzman</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yosef</surname><given-names>N.</given-names></string-name>, <string-name><surname>Bulthaup</surname><given-names>B.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans</article-title>. <source>Science</source>. <year>2022</year>; <volume>376</volume>:<fpage>eabl4896</fpage>.<pub-id pub-id-type="pmid">35549404</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Jin</surname><given-names>X.</given-names></string-name>, <string-name><surname>Tsueng</surname><given-names>G.</given-names></string-name>, <string-name><surname>Afrasiabi</surname><given-names>C.</given-names></string-name>, <string-name><surname>Su</surname><given-names>A.I.</given-names></string-name></person-group><article-title>BioGPS: building your own mash-up of gene annotations and expression profiles</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D313</fpage>–<lpage>D316</lpage>.<pub-id pub-id-type="pmid">26578587</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><collab>HuBMAP Consortium</collab><article-title>The human body at cellular resolution: the NIH Human Biomolecular Atlas Program</article-title>. <source>Nature</source>. <year>2019</year>; <volume>574</volume>:<fpage>187</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">31597973</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Regev</surname><given-names>A.</given-names></string-name>, <string-name><surname>Teichmann</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Lander</surname><given-names>E.S.</given-names></string-name>, <string-name><surname>Amit</surname><given-names>I.</given-names></string-name>, <string-name><surname>Benoist</surname><given-names>C.</given-names></string-name>, <string-name><surname>Birney</surname><given-names>E.</given-names></string-name>, <string-name><surname>Bodenmiller</surname><given-names>B.</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>P.</given-names></string-name>, <string-name><surname>Carninci</surname><given-names>P.</given-names></string-name>, <string-name><surname>Clatworthy</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Human Cell Atlas</article-title>. <source>eLife</source>. <year>2017</year>; <volume>6</volume>:<fpage>e27041</fpage>.<pub-id pub-id-type="pmid">29206104</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lizio</surname><given-names>M.</given-names></string-name>, <string-name><surname>Abugessaisa</surname><given-names>I.</given-names></string-name>, <string-name><surname>Noguchi</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hasegawa</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hon</surname><given-names>C.C.</given-names></string-name>, <string-name><surname>de Hoon</surname><given-names>M.</given-names></string-name>, <string-name><surname>Severin</surname><given-names>J.</given-names></string-name>, <string-name><surname>Oki</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hayashizaki</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Update of the FANTOM web resource: expansion to provide additional transcriptome atlases</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D752</fpage>–<lpage>D758</lpage>.<pub-id pub-id-type="pmid">30407557</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hulstaert</surname><given-names>E.</given-names></string-name>, <string-name><surname>Morlion</surname><given-names>A.</given-names></string-name>, <string-name><surname>Avila Cobos</surname><given-names>F.</given-names></string-name>, <string-name><surname>Verniers</surname><given-names>K.</given-names></string-name>, <string-name><surname>Nuytens</surname><given-names>J.</given-names></string-name>, <string-name><surname>Vanden Eynde</surname><given-names>E.</given-names></string-name>, <string-name><surname>Yigit</surname><given-names>N.</given-names></string-name>, <string-name><surname>Anckaert</surname><given-names>J.</given-names></string-name>, <string-name><surname>Geerts</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hindryckx</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Charting extracellular transcriptomes in the Human Biofluid RNA Atlas</article-title>. <source>Cell Rep.</source><year>2020</year>; <volume>33</volume>:<fpage>108552</fpage>.<pub-id pub-id-type="pmid">33378673</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thul</surname><given-names>P.J.</given-names></string-name>, <string-name><surname>Lindskog</surname><given-names>C.</given-names></string-name></person-group><article-title>The Human Protein Atlas: a spatial map of the human proteome</article-title>. <source>Protein Sci.</source><year>2018</year>; <volume>27</volume>:<fpage>233</fpage>–<lpage>244</lpage>.<pub-id pub-id-type="pmid">28940711</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>L.</given-names></string-name>, <string-name><surname>Weigao</surname><given-names>E.</given-names></string-name>, <string-name><surname>Suo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>H</given-names></string-name><etal>et al</etal>.</person-group><article-title>Construction of a cross-species cell landscape at single-cell level</article-title>. <source>Nucleic Acids Res.</source><year>2023</year>; <volume>51</volume>:<fpage>501</fpage>–<lpage>516</lpage>.<pub-id pub-id-type="pmid">35929025</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sunkin</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Ng</surname><given-names>L.</given-names></string-name>, <string-name><surname>Lau</surname><given-names>C.</given-names></string-name>, <string-name><surname>Dolbeare</surname><given-names>T.</given-names></string-name>, <string-name><surname>Gilbert</surname><given-names>T.L.</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Hawrylycz</surname><given-names>M.</given-names></string-name>, <string-name><surname>Dang</surname><given-names>C.</given-names></string-name></person-group><article-title>Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system</article-title>. <source>Nucleic Acids Res.</source><year>2013</year>; <volume>41</volume>:<fpage>D996</fpage>–<lpage>D1008</lpage>.<pub-id pub-id-type="pmid">23193282</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Pinto</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Getnet</surname><given-names>D.</given-names></string-name>, <string-name><surname>Nirujogi</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Manda</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Chaerkady</surname><given-names>R.</given-names></string-name>, <string-name><surname>Madugundu</surname><given-names>A.K.</given-names></string-name>, <string-name><surname>Kelkar</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Isserlin</surname><given-names>R.</given-names></string-name>, <string-name><surname>Jain</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A draft map of the human proteome</article-title>. <source>Nature</source>. <year>2014</year>; <volume>509</volume>:<fpage>575</fpage>–<lpage>581</lpage>.<pub-id pub-id-type="pmid">24870542</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ghandi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>F.W.</given-names></string-name>, <string-name><surname>Jane-Valbuena</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kryukov</surname><given-names>G.V.</given-names></string-name>, <string-name><surname>Lo</surname><given-names>C.C.</given-names></string-name>, <string-name><surname>McDonald</surname><given-names>E.R.</given-names><suffix>3rd</suffix></string-name>, <string-name><surname>Barretina</surname><given-names>J.</given-names></string-name>, <string-name><surname>Gelfand</surname><given-names>E.T.</given-names></string-name>, <string-name><surname>Bielski</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Next-generation characterization of the Cancer Cell Line Encyclopedia</article-title>. <source>Nature</source>. <year>2019</year>; <volume>569</volume>:<fpage>503</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">31068700</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clough</surname><given-names>E.</given-names></string-name>, <string-name><surname>Barrett</surname><given-names>T.</given-names></string-name></person-group><article-title>The Gene Expression Omnibus database</article-title>. <source>Methods Mol. Biol.</source><year>2016</year>; <volume>1418</volume>:<fpage>93</fpage>–<lpage>110</lpage>.<pub-id pub-id-type="pmid">27008011</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parkinson</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kapushesky</surname><given-names>M.</given-names></string-name>, <string-name><surname>Shojatalab</surname><given-names>M.</given-names></string-name>, <string-name><surname>Abeygunawardena</surname><given-names>N.</given-names></string-name>, <string-name><surname>Coulson</surname><given-names>R.</given-names></string-name>, <string-name><surname>Farne</surname><given-names>A.</given-names></string-name>, <string-name><surname>Holloway</surname><given-names>E.</given-names></string-name>, <string-name><surname>Kolesnykov</surname><given-names>N.</given-names></string-name>, <string-name><surname>Lilja</surname><given-names>P.</given-names></string-name>, <string-name><surname>Lukk</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ArrayExpress—a public database of microarray experiments and gene expression profiles</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>; <volume>35</volume>:<fpage>D747</fpage>–<lpage>D750</lpage>.<pub-id pub-id-type="pmid">17132828</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F.Y.</given-names></string-name>, <string-name><surname>Charles</surname><given-names>R.</given-names></string-name>, <string-name><surname>Solomon</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ling</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Imada</surname><given-names>E.L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Joseph</surname><given-names>L.</given-names></string-name>, <string-name><surname>Leek</surname><given-names>J.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>recount3: summaries and queries for large-scale RNA-seq expression and splicing</article-title>. <source>Genome Biol.</source><year>2021</year>; <volume>22</volume>:<fpage>323</fpage>.<pub-id pub-id-type="pmid">34844637</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lachmann</surname><given-names>A.</given-names></string-name>, <string-name><surname>Torre</surname><given-names>D.</given-names></string-name>, <string-name><surname>Keenan</surname><given-names>A.B.</given-names></string-name>, <string-name><surname>Jagodnik</surname><given-names>K.M.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>H.J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Silverstein</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Ma’ayan</surname><given-names>A.</given-names></string-name></person-group><article-title>Massive mining of publicly available RNA-seq data from human and mouse</article-title>. <source>Nat. Commun.</source><year>2018</year>; <volume>9</volume>:<fpage>1366</fpage>.<pub-id pub-id-type="pmid">29636450</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leland</surname><given-names>M.</given-names></string-name>, <string-name><surname>Healy</surname><given-names>J.</given-names></string-name>, <string-name><surname>Saul</surname><given-names>N.</given-names></string-name>, <string-name><surname>Grossberger</surname><given-names>L</given-names></string-name></person-group><article-title>UMAP: uniform manifold approximation and projection</article-title>. <source>J. Open Source Softw.</source><year>2018</year>; <volume>3</volume>:<fpage>861</fpage>.</mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Keller</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Gold</surname><given-names>I.</given-names></string-name>, <string-name><surname>McCallum</surname><given-names>C.</given-names></string-name>, <string-name><surname>Manz</surname><given-names>T.</given-names></string-name>, <string-name><surname>Kharchenko</surname><given-names>P.V.</given-names></string-name>, <string-name><surname>Gehlenborg</surname><given-names>N.</given-names></string-name></person-group><article-title>Vitessce: a framework for integrative visualization of multi-modal and spatially-resolved single-cell data</article-title>. <year>2021</year>; <comment>OSF Preprints doi:</comment><comment>18 October 2021, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.31219/osf.io/y8thv</pub-id>.</mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bosse</surname><given-names>K.R.</given-names></string-name>, <string-name><surname>Raman</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lane</surname><given-names>M.</given-names></string-name>, <string-name><surname>Martinez</surname><given-names>D.</given-names></string-name>, <string-name><surname>Heitzeneder</surname><given-names>S.</given-names></string-name>, <string-name><surname>Rathi</surname><given-names>K.S.</given-names></string-name>, <string-name><surname>Kendsersky</surname><given-names>N.M.</given-names></string-name>, <string-name><surname>Randall</surname><given-names>M.</given-names></string-name>, <string-name><surname>Donovan</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma</article-title>. <source>Cancer Cell</source>. <year>2017</year>; <volume>32</volume>:<fpage>295</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">28898695</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peters</surname><given-names>C.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>S.</given-names></string-name></person-group><article-title>Antibody–drug conjugates as novel anti-cancer chemotherapeutics</article-title>. <source>Biosci. Rep.</source><year>2015</year>; <volume>35</volume>:<fpage>e00225</fpage>.<pub-id pub-id-type="pmid">26182432</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sadelain</surname><given-names>M.</given-names></string-name>, <string-name><surname>Riviere</surname><given-names>I.</given-names></string-name>, <string-name><surname>Brentjens</surname><given-names>R.</given-names></string-name></person-group><article-title>Targeting tumours with genetically enhanced T lymphocytes</article-title>. <source>Nat. Rev. Cancer</source>. <year>2003</year>; <volume>3</volume>:<fpage>35</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">12509765</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ho</surname><given-names>W.Y.</given-names></string-name>, <string-name><surname>Blattman</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Dossett</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>Yee</surname><given-names>C.</given-names></string-name>, <string-name><surname>Greenberg</surname><given-names>P.D.</given-names></string-name></person-group><article-title>Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction</article-title>. <source>Cancer Cell</source>. <year>2003</year>; <volume>3</volume>:<fpage>431</fpage>–<lpage>437</lpage>.<pub-id pub-id-type="pmid">12781360</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Orentas</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Wen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Mackall</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Khan</surname><given-names>J.</given-names></string-name></person-group><article-title>Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers</article-title>. <source>Front. Oncol.</source><year>2012</year>; <volume>2</volume>:<fpage>194</fpage>.<pub-id pub-id-type="pmid">23251904</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Bangayan</surname><given-names>N.J.</given-names></string-name>, <string-name><surname>Chai</surname><given-names>T.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Pariva</surname><given-names>T.E.</given-names></string-name>, <string-name><surname>Yun</surname><given-names>S.</given-names></string-name>, <string-name><surname>Vashisht</surname><given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Park</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Corey</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer</article-title>. <source>Proc. Natl Acad. Sci. U.S.A.</source><year>2018</year>; <volume>115</volume>:<fpage>E4473</fpage>–<lpage>E4482</lpage>.<pub-id pub-id-type="pmid">29686080</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferguson</surname><given-names>I.D.</given-names></string-name>, <string-name><surname>Patino-Escobar</surname><given-names>B.</given-names></string-name>, <string-name><surname>Tuomivaara</surname><given-names>S.T.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>Y.T.</given-names></string-name>, <string-name><surname>Nix</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Leung</surname><given-names>K.K.</given-names></string-name>, <string-name><surname>Kasap</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ramos</surname><given-names>E.</given-names></string-name>, <string-name><surname>Nieves Vasquez</surname><given-names>W.</given-names></string-name>, <string-name><surname>Talbot</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance</article-title>. <source>Nat. Commun.</source><year>2022</year>; <volume>13</volume>:<fpage>4121</fpage>.<pub-id pub-id-type="pmid">35840578</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeng</surname><given-names>B.</given-names></string-name>, <string-name><surname>Glicksberg</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>Newbury</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chekalin</surname><given-names>E.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K.</given-names></string-name>, <string-name><surname>Wen</surname><given-names>A.</given-names></string-name>, <string-name><surname>Chow</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B.</given-names></string-name></person-group><article-title>OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features</article-title>. <source>Nat. Protoc.</source><year>2021</year>; <volume>16</volume>:<fpage>728</fpage>–<lpage>753</lpage>.<pub-id pub-id-type="pmid">33361798</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Subramanian</surname><given-names>A.</given-names></string-name>, <string-name><surname>Narayan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Corsello</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Peck</surname><given-names>D.D.</given-names></string-name>, <string-name><surname>Natoli</surname><given-names>T.E.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Gould</surname><given-names>J.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Tubelli</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Asiedu</surname><given-names>J.K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A next generation connectivity map: L1000 platform and the first 1,000,000 profiles</article-title>. <source>Cell</source>. <year>2017</year>; <volume>171</volume>:<fpage>1437</fpage>–<lpage>1452</lpage>.<pub-id pub-id-type="pmid">29195078</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Duan</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Reid</surname><given-names>S.P.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>N.R.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Fernandez</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Rouillard</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Readhead</surname><given-names>B.</given-names></string-name>, <string-name><surname>Tritsch</surname><given-names>S.R.</given-names></string-name>, <string-name><surname>Hodos</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hafner</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>L1000CDS(2): LINCS L1000 characteristic direction signatures search engine</article-title>. <source>NPJ Syst. Biol. Appl.</source><year>2016</year>; <volume>2</volume>:<fpage>16015</fpage>.<pub-id pub-id-type="pmid">28413689</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lachmann</surname><given-names>A.</given-names></string-name>, <string-name><surname>Keenan</surname><given-names>A.B.</given-names></string-name>, <string-name><surname>Ma’ayan</surname><given-names>A.</given-names></string-name></person-group><article-title>L1000FWD: fireworks visualization of drug-induced transcriptomic signatures</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>2150</fpage>–<lpage>2152</lpage>.<pub-id pub-id-type="pmid">29420694</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Evangelista</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>D.J.B.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lachmann</surname><given-names>A.</given-names></string-name>, <string-name><surname>Jeon</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>K.</given-names></string-name>, <string-name><surname>Jagodnik</surname><given-names>K.M.</given-names></string-name>, <string-name><surname>Jenkins</surname><given-names>S.L.</given-names></string-name>, <string-name><surname>Kuleshov</surname><given-names>M.V.</given-names></string-name>, <string-name><surname>Wojciechowicz</surname><given-names>M.L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>SigCom LINCS: data and metadata search engine for a million gene expression signatures</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>W697</fpage>–<lpage>W709</lpage>.<pub-id pub-id-type="pmid">35524556</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Duan</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Flynn</surname><given-names>C.</given-names></string-name>, <string-name><surname>Niepel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hafner</surname><given-names>M.</given-names></string-name>, <string-name><surname>Muhlich</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Fernandez</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Rouillard</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>E.Y.</given-names></string-name>, <string-name><surname>Golub</surname><given-names>T.R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>42</volume>:<fpage>W449</fpage>–<lpage>W460</lpage>.<pub-id pub-id-type="pmid">24906883</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hong</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Park</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>N.</given-names></string-name>, <string-name><surname>Cho</surname><given-names>J.</given-names></string-name>, <string-name><surname>Moon</surname><given-names>S.U.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>J.</given-names></string-name>, <string-name><surname>Jeong</surname><given-names>E.</given-names></string-name>, <string-name><surname>Yoon</surname><given-names>S.</given-names></string-name></person-group><article-title>QSurface: fast identification of surface expression markers in cancers</article-title>. <source>BMC Syst. Biol.</source><year>2018</year>; <volume>12</volume>:<fpage>17</fpage>.<pub-id pub-id-type="pmid">29560830</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maglott</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ostell</surname><given-names>J.</given-names></string-name>, <string-name><surname>Pruitt</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Tatusova</surname><given-names>T.</given-names></string-name></person-group><article-title>Entrez Gene: gene-centered information at NCBI</article-title>. <source>Nucleic Acids Res.</source><year>2005</year>; <volume>33</volume>:<fpage>D54</fpage>–<lpage>D58</lpage>.<pub-id pub-id-type="pmid">15608257</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lan</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Quan</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>E.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>C.</given-names></string-name>, <string-name><surname>Luo</surname><given-names>T.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Liao</surname><given-names>G.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>CellMarker: a manually curated resource of cell markers in human and mouse</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D721</fpage>–<lpage>D728</lpage>.<pub-id pub-id-type="pmid">30289549</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tsherniak</surname><given-names>A.</given-names></string-name>, <string-name><surname>Vazquez</surname><given-names>F.</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>P.G.</given-names></string-name>, <string-name><surname>Weir</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Kryukov</surname><given-names>G.</given-names></string-name>, <string-name><surname>Cowley</surname><given-names>G.S.</given-names></string-name>, <string-name><surname>Gill</surname><given-names>S.</given-names></string-name>, <string-name><surname>Harrington</surname><given-names>W.F.</given-names></string-name>, <string-name><surname>Pantel</surname><given-names>S.</given-names></string-name>, <string-name><surname>Krill-Burger</surname><given-names>J.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Defining a cancer dependency map</article-title>. <source>Cell</source>. <year>2017</year>; <volume>170</volume>:<fpage>564</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">28753430</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uhlén</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fagerberg</surname><given-names>L.</given-names></string-name>, <string-name><surname>Hallström</surname><given-names>B.M.</given-names></string-name>, <string-name><surname>Lindskog</surname><given-names>C.</given-names></string-name>, <string-name><surname>Oksvold</surname><given-names>P.</given-names></string-name>, <string-name><surname>Mardinoglu</surname><given-names>A.</given-names></string-name>, <string-name><surname>Sivertsson</surname><given-names>Å.</given-names></string-name>, <string-name><surname>Kampf</surname><given-names>C.</given-names></string-name>, <string-name><surname>Sjöstedt</surname><given-names>E.</given-names></string-name>, <string-name><surname>Asplund</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Tissue-based map of the human proteome</article-title>. <source>Science</source>. <year>2015</year>; <volume>347</volume>:<fpage>1260419</fpage>.<pub-id pub-id-type="pmid">25613900</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>S.</given-names></string-name>, <string-name><surname>Jian</surname><given-names>R.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Chan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>G.</given-names></string-name>, <string-name><surname>Fang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Aguet</surname><given-names>F.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A quantitative proteome map of the human body</article-title>. <source>Cell</source>. <year>2020</year>; <volume>183</volume>:<fpage>269</fpage>–<lpage>283</lpage>.<pub-id pub-id-type="pmid">32916130</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Binder</surname><given-names>J.X.</given-names></string-name>, <string-name><surname>Pletscher-Frankild</surname><given-names>S.</given-names></string-name>, <string-name><surname>Tsafou</surname><given-names>K.</given-names></string-name>, <string-name><surname>Stolte</surname><given-names>C.</given-names></string-name>, <string-name><surname>O’Donoghue</surname><given-names>S.I.</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>R.</given-names></string-name>, <string-name><surname>Jensen</surname><given-names>L.J.</given-names></string-name></person-group><article-title>COMPARTMENTS: unification and visualization of protein subcellular localization evidence</article-title>. <source>Database (Oxford)</source>. <year>2014</year>; <volume>2014</volume>:<fpage>bau012</fpage>.<pub-id pub-id-type="pmid">24573882</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Virtanen</surname><given-names>P.</given-names></string-name>, <string-name><surname>Gommers</surname><given-names>R.</given-names></string-name>, <string-name><surname>Oliphant</surname><given-names>T.E.</given-names></string-name>, <string-name><surname>Haberland</surname><given-names>M.</given-names></string-name>, <string-name><surname>Reddy</surname><given-names>T.</given-names></string-name>, <string-name><surname>Cournapeau</surname><given-names>D.</given-names></string-name>, <string-name><surname>Burovski</surname><given-names>E.</given-names></string-name>, <string-name><surname>Peterson</surname><given-names>P.</given-names></string-name>, <string-name><surname>Weckesser</surname><given-names>W.</given-names></string-name>, <string-name><surname>Bright</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>SciPy 1.0: fundamental algorithms for scientific computing in Python</article-title>. <source>Nat. Methods</source>. <year>2020</year>; <volume>17</volume>:<fpage>261</fpage>–<lpage>272</lpage>.<pub-id pub-id-type="pmid">32015543</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tomczak</surname><given-names>K.</given-names></string-name>, <string-name><surname>Czerwińska</surname><given-names>P.</given-names></string-name>, <string-name><surname>Wiznerowicz</surname><given-names>M.</given-names></string-name></person-group><article-title>The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge</article-title>. <source>Contemp. Oncol. (Pozn)</source>. <year>2015</year>; <volume>19</volume>:<fpage>A68</fpage>–<lpage>A77</lpage>.<pub-id pub-id-type="pmid">25691825</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Traag</surname><given-names>V.A.</given-names></string-name>, <string-name><surname>Waltman</surname><given-names>L.</given-names></string-name>, <string-name><surname>van Eck</surname><given-names>N.J.</given-names></string-name></person-group><article-title>From Louvain to Leiden: guaranteeing well-connected communities</article-title>. <source>Sci. Rep.</source><year>2019</year>; <volume>9</volume>:<fpage>5233</fpage>.<pub-id pub-id-type="pmid">30914743</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolf</surname><given-names>F.A.</given-names></string-name>, <string-name><surname>Angerer</surname><given-names>P.</given-names></string-name>, <string-name><surname>Theis</surname><given-names>F.J.</given-names></string-name></person-group><article-title>SCANPY: large-scale single-cell gene expression data analysis</article-title>. <source>Genome Biol.</source><year>2018</year>; <volume>19</volume>:<fpage>15</fpage>.<pub-id pub-id-type="pmid">29409532</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grossman</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Heath</surname><given-names>A.P.</given-names></string-name>, <string-name><surname>Ferretti</surname><given-names>V.</given-names></string-name>, <string-name><surname>Varmus</surname><given-names>H.E.</given-names></string-name>, <string-name><surname>Lowy</surname><given-names>D.R.</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>W.A.</given-names></string-name>, <string-name><surname>Staudt</surname><given-names>L.M.</given-names></string-name></person-group><article-title>Toward a shared vision for cancer genomic data</article-title>. <source>N. Engl. J. Med.</source><year>2016</year>; <volume>375</volume>:<fpage>1109</fpage>–<lpage>1112</lpage>.<pub-id pub-id-type="pmid">27653561</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Diehl</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Meehan</surname><given-names>T.F.</given-names></string-name>, <string-name><surname>Bradford</surname><given-names>Y.M.</given-names></string-name>, <string-name><surname>Brush</surname><given-names>M.H.</given-names></string-name>, <string-name><surname>Dahdul</surname><given-names>W.M.</given-names></string-name>, <string-name><surname>Dougall</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>He</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Osumi-Sutherland</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ruttenberg</surname><given-names>A.</given-names></string-name>, <string-name><surname>Sarntivijai</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Cell Ontology 2016: enhanced content, modularization, and ontology interoperability</article-title>. <source>J. Biomed. Semantics</source>. <year>2016</year>; <volume>7</volume>:<fpage>44</fpage>.<pub-id pub-id-type="pmid">27377652</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gremse</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schomburg</surname><given-names>I.</given-names></string-name>, <string-name><surname>Grote</surname><given-names>A.</given-names></string-name>, <string-name><surname>Scheer</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ebeling</surname><given-names>C.</given-names></string-name>, <string-name><surname>Schomburg</surname><given-names>D</given-names></string-name></person-group><article-title>The BRENDA Tissue Ontology (BTO): the first all-integrating ontology of all organisms for enzyme sources</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>; <volume>39</volume>:<fpage>D507</fpage>–<lpage>D513</lpage>.<pub-id pub-id-type="pmid">21030441</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Placzek</surname><given-names>S.</given-names></string-name>, <string-name><surname>Schomburg</surname><given-names>I.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>A.</given-names></string-name>, <string-name><surname>Jeske</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ulbrich</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tillack</surname><given-names>J.</given-names></string-name>, <string-name><surname>Schomburg</surname><given-names>D</given-names></string-name></person-group><article-title>BRENDA in 2017: new perspectives and new tools in BRENDA</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>45</volume>:<fpage>D380</fpage>–<lpage>D388</lpage>.<pub-id pub-id-type="pmid">27924025</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ooi</surname><given-names>A.T.</given-names></string-name>, <string-name><surname>Gower</surname><given-names>A.C.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>K.X.</given-names></string-name>, <string-name><surname>Vick</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Hong</surname><given-names>L.</given-names></string-name>, <string-name><surname>Nagao</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wallace</surname><given-names>W.D.</given-names></string-name>, <string-name><surname>Elashoff</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Walser</surname><given-names>T.C.</given-names></string-name>, <string-name><surname>Dubinett</surname><given-names>S.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis</article-title>. <source>Cancer Prev. Res. (Phila.)</source>. <year>2014</year>; <volume>7</volume>:<fpage>487</fpage>–<lpage>495</lpage>.<pub-id pub-id-type="pmid">24618292</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rouillard</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Gundersen</surname><given-names>G.W.</given-names></string-name>, <string-name><surname>Fernandez</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Monteiro</surname><given-names>C.D.</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Ma’ayan</surname><given-names>A.</given-names></string-name></person-group><article-title>The Harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins</article-title>. <source>Database (Oxford)</source>. <year>2016</year>; <volume>2016</volume>:<fpage>baw100</fpage>.<pub-id pub-id-type="pmid">27374120</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Lachmann</surname><given-names>A.</given-names></string-name>, <string-name><surname>Rizzo</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bartal</surname><given-names>A.</given-names></string-name>, <string-name><surname>Jeon</surname><given-names>M.</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>D.J.B.</given-names></string-name>, <string-name><surname>Ma’ayan</surname><given-names>A</given-names></string-name></person-group><article-title>PrismExp: predicting human gene function by partitioning massive RNA-seq co-expression data</article-title>. <year>2021</year>; <comment>bioRxiv doi:</comment><comment>21 January 2021, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.1101/2021.01.20.427528</pub-id>.</mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clarke</surname><given-names>D.J.B.</given-names></string-name>, <string-name><surname>Kuleshov</surname><given-names>M.V.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Evangelista</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Meyers</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Kropiwnicki</surname><given-names>E.</given-names></string-name>, <string-name><surname>Jenkins</surname><given-names>S.L.</given-names></string-name>, <string-name><surname>Ma’ayan</surname><given-names>A.</given-names></string-name></person-group><article-title>Gene and drug landing page aggregator</article-title>. <source>Bioinform. Adv.</source><year>2022</year>; <volume>2</volume>:<fpage>vbac013</fpage>.<pub-id pub-id-type="pmid">35368424</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xia</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Ouyang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zou</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.</given-names></string-name>, <string-name><surname>Yi</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>E.</given-names></string-name></person-group><article-title>The expression, functions, interactions and prognostic values of PTPRZ1: a review and bioinformatic analysis</article-title>. <source>J. Cancer</source>. <year>2019</year>; <volume>10</volume>:<fpage>1663</fpage>–<lpage>1674</lpage>.<pub-id pub-id-type="pmid">31205522</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Makinoshima</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ishii</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kojima</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fujii</surname><given-names>S.</given-names></string-name>, <string-name><surname>Higuchi</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kuwata</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ochiai</surname><given-names>A.</given-names></string-name></person-group><article-title>PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma</article-title>. <source>BMC Cancer</source>. <year>2012</year>; <volume>12</volume>:<fpage>537</fpage>.<pub-id pub-id-type="pmid">23170925</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname><given-names>R.</given-names></string-name>, <string-name><surname>Jian</surname><given-names>X.C.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>D.Y.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name></person-group><article-title>Expression of PTPRZ1 in oral squamous cell carcinoma originated from oral submucous fibrosis and its clinical significance</article-title>. <source>Shanghai Kou Qiang Yi Xue</source>. <year>2017</year>; <volume>26</volume>:<fpage>198</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="pmid">28815252</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reaves</surname><given-names>D.K.</given-names></string-name>, <string-name><surname>Hoadley</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Fagan-Solis</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Jima</surname><given-names>D.D.</given-names></string-name>, <string-name><surname>Bereman</surname><given-names>M.</given-names></string-name>, <string-name><surname>Thorpe</surname><given-names>L.</given-names></string-name>, <string-name><surname>Hicks</surname><given-names>J.</given-names></string-name>, <string-name><surname>McDonald</surname><given-names>D.</given-names></string-name>, <string-name><surname>Troester</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Perou</surname><given-names>C.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Nuclear localized LSR: a novel regulator of breast cancer behavior and tumorigenesis</article-title>. <source>Mol. Cancer Res.</source><year>2017</year>; <volume>15</volume>:<fpage>165</fpage>–<lpage>178</lpage>.<pub-id pub-id-type="pmid">27856957</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>C.</given-names></string-name></person-group><article-title>LSR promotes cell proliferation and invasion in lung cancer</article-title>. <source>Comput. Math. Methods Med.</source><year>2021</year>; <volume>2021</volume>:<fpage>6651907</fpage>.<pub-id pub-id-type="pmid">33763152</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peluso</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Saunders</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Claffey</surname><given-names>K.P.</given-names></string-name>, <string-name><surname>Phoenix</surname><given-names>K.</given-names></string-name></person-group><article-title>Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1</article-title>. <source>J. Clin. Endocrinol. Metab.</source><year>2008</year>; <volume>93</volume>:<fpage>1592</fpage>–<lpage>1599</lpage>.<pub-id pub-id-type="pmid">18319313</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Friel</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Pru</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>N.C.</given-names></string-name>, <string-name><surname>McCallum</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>Blok</surname><given-names>L.J.</given-names></string-name>, <string-name><surname>Shioda</surname><given-names>T.</given-names></string-name>, <string-name><surname>Peluso</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Rueda</surname><given-names>B.R.</given-names></string-name>, <string-name><surname>Pru</surname><given-names>J.K.</given-names></string-name></person-group><article-title>Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors</article-title>. <source>Cancer Lett.</source><year>2015</year>; <volume>356</volume>:<fpage>434</fpage>–<lpage>442</lpage>.<pub-id pub-id-type="pmid">25304370</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
